220 related articles for article (PubMed ID: 10832109)
1. Prognostic indicators in differentiated thyroid carcinoma.
Dean DS; Hay ID
Cancer Control; 2000; 7(3):229-39. PubMed ID: 10832109
[TBL] [Abstract][Full Text] [Related]
2. [Thyroid gland carcinoma].
Schmid KW
Praxis (Bern 1994); 1998 Mar; 87(11):367-74. PubMed ID: 9562812
[TBL] [Abstract][Full Text] [Related]
3. [Classification, staging, prognostic factors and risk factors in thyroid carcinoma].
Zivaljević V; Paunović I; Diklić A; Krgović K; Zivić R; Kazić M; Kalezić N; Bozić V; Tatić S; Havelka M
Acta Chir Iugosl; 2003; 50(3):57-60. PubMed ID: 15179756
[TBL] [Abstract][Full Text] [Related]
4. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
[TBL] [Abstract][Full Text] [Related]
5. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
[TBL] [Abstract][Full Text] [Related]
6. Familial follicular cell tumors: classification and morphological characteristics.
Nosé V
Endocr Pathol; 2010 Dec; 21(4):219-26. PubMed ID: 20878367
[TBL] [Abstract][Full Text] [Related]
7. Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.
Sherman SI; Brierley JD; Sperling M; Ain KB; Bigos ST; Cooper DS; Haugen BR; Ho M; Klein I; Ladenson PW; Robbins J; Ross DS; Specker B; Taylor T; Maxon HR
Cancer; 1998 Sep; 83(5):1012-21. PubMed ID: 9731906
[TBL] [Abstract][Full Text] [Related]
8. [Differentiated thyroid cancer--staging and prognostic systems].
Dănilă R; Andriescu L; Grigorovici A; Dragomir C; Găluşcă B; Vulpoi C; Ungureanu C; Mogoş V
Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):71-6. PubMed ID: 16607831
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors in differentiated thyroid gland carcinoma].
Fonseca E; Soares P; Rossi S; Sobrinho-Simões M
Pathologe; 1997 Jul; 18(4):275-85. PubMed ID: 9380603
[TBL] [Abstract][Full Text] [Related]
10. Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study.
Aratake Y; Nomura H; Kotani T; Marutsuka K; Kobayashi K; Kuma K; Miyauchi A; Okayama A; Tamura K
Am J Clin Pathol; 2006 Mar; 125(3):399-406. PubMed ID: 16613343
[TBL] [Abstract][Full Text] [Related]
11. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.
D'Avanzo A; Ituarte P; Treseler P; Kebebew E; Wu J; Wong M; Duh QY; Siperstein AE; Clark OH
Thyroid; 2004 Jun; 14(6):453-8. PubMed ID: 15242573
[TBL] [Abstract][Full Text] [Related]
12. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer.
Liska J; Altanerova V; Galbavy S; Stvrtina S; Brtko J
Endocr Regul; 2005 Sep; 39(3):73-83. PubMed ID: 16468229
[TBL] [Abstract][Full Text] [Related]
13. Are prognostic scoring systems of value in patients with follicular thyroid carcinoma?
Ríos A; Rodríguez JM; Ferri B; Matínez-Barba E; Febrero B; Parrilla P
Eur J Endocrinol; 2013 Dec; 169(6):821-7. PubMed ID: 24050927
[TBL] [Abstract][Full Text] [Related]
14. The demise of follicular carcinoma of the thyroid gland.
LiVolsi VA; Asa SL
Thyroid; 1994; 4(2):233-6. PubMed ID: 7920009
[TBL] [Abstract][Full Text] [Related]
15. Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system?
Besic N; Zgajnar J; Hocevar M; Frkovic-Grazio S
Thyroid; 2005 May; 15(5):439-48. PubMed ID: 15929665
[TBL] [Abstract][Full Text] [Related]
16. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
17. [Current anatomopathological aspects of differentiated thyroid cancers of follicular (vesicular) origin: value and necessity of a common language].
Franc B
Ann Chir; 1995; 49(10):909-21. PubMed ID: 8787318
[TBL] [Abstract][Full Text] [Related]
18. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
19. Mixed medullary-follicular and medullary-papillary carcinoma of the thyroid: one or two entities?
Michal M; Curík R; Macák J; Ludvíková M; Dĕdic K
Zentralbl Pathol; 1993 Nov; 139(4-5):333-5. PubMed ID: 8130165
[TBL] [Abstract][Full Text] [Related]
20. [C-cells in malignant epithelial tumors of the thyroid gland].
Derizhanova IS; Sidorenko SI
Vopr Onkol; 1998; 44(6):686-90. PubMed ID: 10087965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
